PAVmed (PAVM) Short Interest Ratio & Short Volume $0.52 +0.03 (+6.16%) Closing price 04:00 PM EasternExtended Trading$0.51 -0.01 (-1.73%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAVmed Short Interest DataPAVmed (PAVM) has a short interest of 211,300 shares, representing 1.51% of the float (the number of shares available for trading by the public). This marks a -8.05% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 188,758 shares to cover all short positions.Current Short Interest211,300 sharesPrevious Short Interest229,800 sharesChange Vs. Previous Month-8.05%Dollar Volume Sold Short$121.65 thousandShort Interest Ratio1.1 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares21,930,000 sharesFloat Size13,990,000 sharesShort Percent of Float1.51%Today's Trading Volume913,288 sharesAverage Trading Volume188,758 sharesToday's Volume Vs. Average484% Short Selling PAVmed? Sign up to receive the latest short interest report for PAVmed and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPAVM Short Interest Over TimePAVM Days to Cover Over TimePAVM Percentage of Float Shorted Over Time PAVmed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025211,300 shares $121.65 thousand -8.1%1.5%1.1 $0.58 7/15/2025229,800 shares $131.68 thousand -30.2%1.6%1.5 $0.57 6/30/2025329,400 shares $197.74 thousand +1.6%2.4%2 $0.60 6/15/2025324,300 shares $207.07 thousand -7.6%2.4%2 $0.64 5/31/2025351,000 shares $214.07 thousand +6.4%2.6%2.2 $0.61 5/15/2025330,000 shares $207.87 thousand +41.5%2.5%2.2 $0.63 4/30/2025233,300 shares $169.05 thousand -1.7%2.1%1.4 $0.72 4/15/2025237,400 shares $169.81 thousand -38.4%2.2%1.4 $0.72 3/31/2025385,500 shares $278.10 thousand +41.7%3.6%2.1 $0.72 3/15/2025272,000 shares $179.52 thousand -14.7%3.8%1.2 $0.66 Get the Latest News and Ratings for PAVM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025318,700 shares $235.84 thousand +21.4%4.5%1.5 $0.74 2/15/2025262,500 shares $207.38 thousand -25.9%2.7%1.2 $0.79 1/31/2025354,000 shares $235.06 thousand -0.9%3.6%2 $0.66 1/15/2025357,100 shares $231.76 thousand -17.5%3.7%2.3 $0.65 12/31/2024432,900 shares $271.64 thousand +40.1%4.7%3.2 $0.63 12/15/2024308,900 shares $236.18 thousand +7.8%3.3%3.1 $0.76 11/30/2024286,500 shares $277.91 thousand +6.2%3.1%4.4 $0.97 11/15/2024269,900 shares $307.69 thousand -4.0%2.9%4.1 $1.14 10/31/2024281,000 shares $300.67 thousand +1.4%3.3%4.6 $1.07 10/15/2024277,100 shares $279.87 thousand +2.5%3.2%4.1 $1.01 9/30/2024270,400 shares $332.59 thousand +0.4%3.1%3.5 $1.23 9/15/2024269,400 shares $479.53 thousand -8.2%2.9%3.4 $1.78 8/31/2024293,400 shares $266.99 thousand +19.0%3.2%3.6 $0.91 8/15/2024246,600 shares $172.87 thousand +3.6%2.7%3.8 $0.70 7/31/2024238,100 shares $205.94 thousand -9.8%2.9%3.7 $0.86 7/15/2024264,100 shares $248.25 thousand No Change3.2%4.1 $0.94 2/29/2024356,400 shares $944.46 thousand -10.1%5.4%4.3 $2.65 2/15/2024396,500 shares $787.05 thousand +44.5%5.4%5.2 $1.99 1/31/2024274,400 shares $636.61 thousand -10.8%3.8%3.9 $2.32 1/15/2024307,700 shares $1.01 million +14.9%3.8%4.8 $3.29 12/31/2023267,700 shares $1.10 million -1.5%3.7%4.8 $4.12 12/15/2023271,700 shares $1.01 million +27.2%3.7%5.7 $3.72 11/30/2023213,600 shares $990.04 thousand -93.5%3.0%4.8 $4.64 11/15/20233,270,000 shares $722.67 thousand -9.4%N/A5.1 $0.22 10/31/20233,610,000 shares $943.29 thousand -1.4%N/A5.2 $0.26 10/15/20233,660,000 shares $1.08 million +9.6%N/A5.2 $0.29 9/30/20233,340,000 shares $983.96 thousand -8.2%N/A4.7 $0.29 9/15/20233,640,000 shares $1.16 million -10.3%N/A4.9 $0.32 8/31/20234,060,000 shares $1.27 million +1.5%N/A6.1 $0.31 8/15/20234,000,000 shares $1.22 million +2.3%N/A7.6 $0.31A Major Economic Change Is Happening Now (Ad)Louis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and earning a reputation for fact-based analysis, not sensationalism. That’s why his latest economic warning is turning so many heads. In his new report, Louis reveals how recent policies are accelerating a massive economic shift. While headlines point to strong numbers, everyday Americans feel the squeeze as prices climb and industries are reshaped. According to Louis, this transformation could determine who falls behind — and who builds lasting wealth.Read Louis Navellier’s urgent report here 7/31/20233,910,000 shares $1.47 million -7.1%N/A8.2 $0.38 7/15/20234,210,000 shares $1.64 million -4.5%N/A8.6 $0.39 6/30/20234,410,000 shares $1.80 million +4.8%N/A8.5 $0.41 6/15/20234,210,000 shares $1.76 million -8.5%N/A8.5 $0.42 5/31/20234,600,000 shares $1.85 million -8.6%N/A9.6 $0.40 5/15/20235,030,000 shares $2.54 million -2.3%N/A12 $0.50 4/30/20235,150,000 shares $2.27 million -5.9%N/A11.5 $0.44 4/15/20235,470,000 shares $2.41 million -1.8%N/A12.3 $0.44 3/31/20235,570,000 shares $2.08 million -21.9%6.7%12.2 $0.37 3/15/20237,130,000 shares $3.07 million -3.1%8.5%13.9 $0.43 2/28/20237,360,000 shares $3.41 million +14.8%9.2%13.2 $0.46 2/15/20236,410,000 shares $3.08 million +8.1%8.1%10.4 $0.48 1/31/20235,930,000 shares $3.03 million -11.4%N/A8.7 $0.51 1/15/20236,690,000 shares $3.91 million +13.4%N/A9.5 $0.59 12/30/20225,900,000 shares $2.83 million +8.5%N/A8.6 $0.48 12/15/20225,440,000 shares $2.79 million -0.4%N/A7.7 $0.51 11/30/20225,460,000 shares $3.82 million -1.8%N/A8 $0.70 11/15/20225,560,000 shares $5.35 million -5.1%N/A8.9 $0.96 10/31/20225,860,000 shares $7.27 million +3.9%7.1%7.1 $1.24 10/15/20225,640,000 shares $5.55 million +15.6%6.8%5.9 $0.98 9/30/20224,880,000 shares $4.20 million +6.1%5.9%5.2 $0.86 9/15/20224,600,000 shares $5.15 million -1.1%5.6%4.3 $1.12 8/31/20224,650,000 shares $5.53 million -21.3%5.6%4 $1.19 8/15/20225,910,000 shares $13.42 million -9.9%7.2%4.6 $2.27 7/31/20226,560,000 shares $7.94 million +2.2%8.2%5.2 $1.21 7/15/20226,420,000 shares $6.81 million -10.5%8.0%4.3 $1.06 6/30/20227,170,000 shares $6.70 million -25.7%9.0%4.5 $0.93 6/15/20229,650,000 shares $9.15 million +3.4%12.1%5.4 $0.95 5/31/20229,330,000 shares $9.42 million +16.8%11.7%5.2 $1.01 5/15/20227,990,000 shares $8.23 million -2.8%10.0%4.5 $1.03 4/30/20228,220,000 shares $10.44 million +14.5%10.3%4.6 $1.27 4/15/20227,180,000 shares $7.61 million +19.5%9.0%4.6 $1.06 3/31/20226,010,000 shares $7.93 million +10.3%7.7%3.8 $1.32 3/15/20225,450,000 shares $6.43 million -0.7%6.9%3.3 $1.18 2/28/20225,490,000 shares $8.40 million +37.3%7.0%3.3 $1.53 2/15/20224,000,000 shares $7.36 million -5.4%5.1%2.2 $1.84 1/31/20224,230,000 shares $7.28 million -3.9%5.4%2.1 $1.72 1/15/20224,400,000 shares $8.49 million -8.0%5.6%2.1 $1.93 12/31/20214,780,000 shares $11.76 million -15.3%6.1%2 $2.46 12/15/20215,640,000 shares $17.48 million -3.8%7.2%2.4 $3.10 11/30/20215,860,000 shares $21.51 million -2.2%7.5%2.4 $3.67 11/15/20215,990,000 shares $29.35 million -2.0%7.6%2.5 $4.90 10/29/20216,110,000 shares $33.18 million +3.7%8.1%2.7 $5.43 10/15/20215,890,000 shares $35.81 million +13.5%7.8%2.6 $6.08 9/30/20215,190,000 shares $44.32 million +10.0%6.9%2.7 $8.54 9/15/20214,720,000 shares $35.35 million +1.9%6.4%2.6 $7.49 8/31/20214,630,000 shares $33.80 million -6.5%6.2%2.7 $7.30 8/13/20214,950,000 shares $30.44 million -8.0%6.7%2.8 $6.15 7/30/20215,380,000 shares $36.96 million +3.9%7.3%2.9 $6.87 7/15/20215,180,000 shares $27.35 million -0.8%7.1%2.7 $5.28A Major Economic Change Is Happening Now (Ad)Louis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and earning a reputation for fact-based analysis, not sensationalism. That’s why his latest economic warning is turning so many heads. In his new report, Louis reveals how recent policies are accelerating a massive economic shift. While headlines point to strong numbers, everyday Americans feel the squeeze as prices climb and industries are reshaped. According to Louis, this transformation could determine who falls behind — and who builds lasting wealth.Read Louis Navellier’s urgent report here 6/30/20215,220,000 shares $33.41 million -0.2%7.1%2.4 $6.40 6/15/20215,230,000 shares $31.69 million -12.5%7.1%1.7 $6.06 5/28/20215,980,000 shares $31.69 million +16.1%8.1%1.8 $5.30 5/14/20215,150,000 shares $20.50 million -5.9%N/A1.4 $3.98 4/30/20215,470,000 shares $25.71 million +6.0%N/A1.1 $4.70 4/15/20215,160,000 shares $25.21 million -12.8%N/A1 $4.89 3/31/20215,920,000 shares $27.41 million +8.2%N/A1.3 $4.63 3/15/20215,470,000 shares $23.74 million -1.8%N/A1.3 $4.34 2/26/20215,570,000 shares $24.90 million +6.5%N/A1.4 $4.47 2/12/20215,230,000 shares $16.79 million +10.3%N/A1.5 $3.21 1/29/20214,740,000 shares $9.76 million -2.5%N/A2.5 $2.06 1/15/20214,860,000 shares $10.06 million +13.6%N/A2.9 $2.07 12/31/20204,280,000 shares $9.03 million +18.9%N/A3 $2.11 12/15/20203,600,000 shares $6.37 million -2.7%N/A3.6 $1.77 11/30/20203,700,000 shares $7.25 million +15.6%N/A6.4 $1.96 11/15/20203,200,000 shares $5.76 million +2.9%N/A5.6 $1.80 10/30/20203,110,000 shares $5.75 million -4.9%N/A5.5 $1.85 10/15/20203,270,000 shares $6.47 million -8.2%N/A5.6 $1.98 9/30/20203,560,000 shares $6.34 million -11.4%N/A6 $1.78 9/15/20204,020,000 shares $7.56 million +0.8%N/A5.7 $1.88 8/31/20203,990,000 shares $7.86 million +11.1%N/A4.9 $1.97 PAVM Short Interest - Frequently Asked Questions What is PAVmed's current short interest? Short interest is the volume of PAVmed shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 211,300 shares of PAVM short. 1.51% of PAVmed's shares are currently sold short. Learn More on PAVmed's current short interest. What is a good short interest ratio for PAVmed? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PAVM shares currently have a short interest ratio of 1.0. Learn More on PAVmed's short interest ratio. What is a good short interest percentage for PAVmed? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.51% of PAVmed's floating shares are currently sold short. Is PAVmed's short interest increasing or decreasing? PAVmed saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 211,300 shares, a drop of 8.1% from the previous total of 229,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is PAVmed's float size? PAVmed currently has issued a total of 21,930,000 shares. Some of PAVmed's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. PAVmed currently has a public float of 13,990,000 shares. How does PAVmed's short interest compare to its competitors? 1.51% of PAVmed's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to PAVmed: Envoy Medical, Inc. (0.90%), Vivos Therapeutics, Inc. (7.89%), Retractable Technologies, Inc. (0.27%), Femasys Inc. (1.41%), SeaStar Medical Holding Corporation (9.79%), DarioHealth Corp. (7.52%), NexGel, Inc. (0.53%), IRIDEX Corporation (2.38%), Allurion Technologies, Inc. (1.79%), NeurAxis, Inc. (0.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short PAVmed stock? Short selling PAVM is an investing strategy that aims to generate trading profit from PAVmed as its price is falling. PAVM shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PAVmed? A short squeeze for PAVmed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PAVM, which in turn drives the price of the stock up even further. How often is PAVmed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PAVM, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies COCH Short Interest VVOS Short Interest RVP Short Interest FEMY Short Interest ICU Short Interest DRIO Short Interest NXGL Short Interest IRIX Short Interest ALUR Short Interest NRXS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PAVM) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s national nightmare is hereWhile the headlines focus on global conflicts, there’s a very different crisis brewing at home. Washington has...Porter & Company | SponsoredIt’s game over for Central BanksCentral banks are losing control. Inflation isn’t fixed, debt is exploding, and stocks have never looked more ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access